Oscillation Effects and Time Variation of the Supernova Neutrino Signal

The neutrinos detected from the next Galactic core-collapse supernova will contain valuable information on the internal dynamics of the explosion. One mechanism leading to a temporal evolution of the neutrino signal is the variation of the induced neutrino flavor mixing driven by changes in the density profile. With one and two dimensional hydrodynamical simulations we identify the behavior and properties of prominent features of the explosion. Using these results we demonstrate the time variation of the neutrino crossing probabilities due to changes in the MSW neutrino transformations as the star explodes by using the S-matrix - Monte Carlo - approach to neutrino propagation. After adopting spectra for the neutrinos emitted from the proto-neutron star we calculate for a Galactic supernova the evolution of the positron spectra within a water Cerenkov detector and the ratio of charged current to neutral current event rates for a heavy water - SNO like - detector and find that these detector signals are feasible probes of a number of explosion features

Crop Updates 2006 - Katanning

This session covers sixteen papers from different authors 2006 SEASONAL OUTLOOK, David Stephens and Michael Meuleners, Department of Agriculture Review of climate model summaries reported in the Department of Agriculture’s growing season outlooks, Meredith Fairbanks, Department of Agriculture Farmers commodity outlook 2006, Thomas Schulz, Department of Agriculture Why is salinity such a difficult problem for plant breeders? T J Flowers, TD Colmer, University of Western Australia Matching nitrogen supply to wheat demand in 2005, Narelle Simpson, Ron McTaggart, Wal Anderson, Lionel Martin and Dave Allen, Department of Agriculture Wheat varieties in 2006, Brenda Shackley, Department of Agriculture Performance of dwarf potential milling oat varieties in Western Australian environments, Raj Malik and Kellie Winfield, Department of Agriculture Field pea lessons for 2006, Rodger Beermir, Department of Agriculture Better returns from Durum wheat, Shahahan Miyan, Department of Agriculture Summer weeds can reduce grain yield and protein, Dr. Abul Hashem, Department of Agriculture, Dr Shahab Pathan, Department of Agriculture, Vikki Osten, Queensland Department of Primary Industries and Fisheries Management of Summer Weeds, Alex Douglas, Department of Agriculture Frost or Friction, Garren Knell, Steve Curtin, Wade Longmuir, Consult Ag Pty Ltd PROFITING FROM MARGINAL LAND SEMINAR Producing Bio-Diesel and rubber from marginal land?? Dr Henry Brockman, Department of Agriculture SGSL Producer network – on ground implementation of saltbush based pastures, Justin Hardy, Arjen Ryder, John Paul Collins and Jessica Johns, Department of Agriculture Enhancing the profitability of “Edenia” using saltbush and perenials, SGSL Producer case study, John Pepall, Jinka’s Hill LCDC Investment in saltland pastures, Allan Herbert, Department of Agricultur

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

BACKGROUND: A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. METHODS: This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. FINDINGS: Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0-75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4-97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8-80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3-4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. INTERPRETATION: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials. FUNDING: UK Research and Innovation, National Institutes for Health Research (NIHR), Coalition for Epidemic Preparedness Innovations, Bill & Melinda Gates Foundation, Lemann Foundation, Rede D'Or, Brava and Telles Foundation, NIHR Oxford Biomedical Research Centre, Thames Valley and South Midland's NIHR Clinical Research Network, and AstraZeneca

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Africa. Participants aged 18 years and older were randomly assigned (1:1) to ChAdOx1 nCoV-19 vaccine or control (meningococcal group A, C, W, and Y conjugate vaccine or saline). Participants in the ChAdOx1 nCoV-19 group received two doses containing 5 × 1010 viral particles (standard dose; SD/SD cohort); a subset in the UK trial received a half dose as their first dose (low dose) and a standard dose as their second dose (LD/SD cohort). The primary efficacy analysis included symptomatic COVID-19 in seronegative participants with a nucleic acid amplification test-positive swab more than 14 days after a second dose of vaccine. Participants were analysed according to treatment received, with data cutoff on Nov 4, 2020. Vaccine efficacy was calculated as 1 - relative risk derived from a robust Poisson regression model adjusted for age. Studies are registered at ISRCTN89951424 and ClinicalTrials.gov, NCT04324606, NCT04400838, and NCT04444674. Findings Between April 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 in Brazil) were included in the interim primary efficacy analysis. In participants who received two standard doses, vaccine efficacy was 62·1% (95% CI 41·0–75·7; 27 [0·6%] of 4440 in the ChAdOx1 nCoV-19 group vs71 [1·6%] of 4455 in the control group) and in participants who received a low dose followed by a standard dose, efficacy was 90·0% (67·4–97·0; three [0·2%] of 1367 vs 30 [2·2%] of 1374; pinteraction=0·010). Overall vaccine efficacy across both groups was 70·4% (95·8% CI 54·8–80·6; 30 [0·5%] of 5807 vs 101 [1·7%] of 5829). From 21 days after the first dose, there were ten cases hospitalised for COVID-19, all in the control arm; two were classified as severe COVID-19, including one death. There were 74 341 person-months of safety follow-up (median 3·4 months, IQR 1·3–4·8): 175 severe adverse events occurred in 168 participants, 84 events in the ChAdOx1 nCoV-19 group and 91 in the control group. Three events were classified as possibly related to a vaccine: one in the ChAdOx1 nCoV-19 group, one in the control group, and one in a participant who remains masked to group allocation. Interpretation ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials

X-ray photoelectron spectroscopy investigation of the valence band offset at beryllium oxide-diamond interfaces (vol 101, 107647, 2020)

DOI of original article: https://doi.org/10.1016/j.diamond.2019.107647

The Role of \u3ci\u3eShewanella oneidensis\u3c/i\u3e MR-1 Outer Surface Structures in Extracellular Electron Transfer

The ability of the metal reducer Shewanella oneidensis MR-1 to generate electricity in microbial fuel cells (MFCs) depends on the activity of a predicted type IV prepilin peptidase; PilD. Analysis of an S. oneidensis MR-1 pilD mutant indicated that it was deficient in pili production (Msh and type IV) and type II secretion (T2S). The requirement for T2S in metal reduction has been previously identified, but the role of pili remains largely unexplored. To define the role of type IV or Msh pili in electron transfer, mutants that lack one or both pilus biogenesis systems were generated and analyzed; a mutant that lacked flagella was also constructed and tested. All mutants were able to reduce insoluble Fe(III) and to generate current in MFCs, in contrast to the T2S mutant that is deficient in both processes. Our results show that loss of metal reduction in a PilD mutant is due to a T2S deficiency, and therefore the absence of c cytochromes from the outer surface of MR-1 cells, and not the loss of pili or flagella. Furthermore, MR-1 mutants deficient in type IV pili or flagella generated more current than the wild type, even though extracellular riboflavin levels were similar in all strains. This enhanced current generating ability is in contrast to a mutant that lacks the outer membrane c cytochromes, MtrC and OmcA. This mutant generated significantly less current than the wild type in an MFC and was unable to reduce Fe(III). These results indicated that although nanofilaments and soluble mediators may play a role in electron transfer, surface exposure of outer membrane c cytochromes was the determining factor in extracellular electron transfer in S. oneidensis MR-1

Crop Updates 2006 - Katanning

This session covers sixteen papers from different authors 2006 SEASONAL OUTLOOK, David Stephens and Michael Meuleners, Department of Agriculture Review of climate model summaries reported in the Department of Agriculture’s growing season outlooks, Meredith Fairbanks, Department of Agriculture Farmers commodity outlook 2006, Thomas Schulz, Department of Agriculture Why is salinity such a difficult problem for plant breeders? T J Flowers, TD Colmer, University of Western Australia Matching nitrogen supply to wheat demand in 2005, Narelle Simpson, Ron McTaggart, Wal Anderson, Lionel Martin and Dave Allen, Department of Agriculture Wheat varieties in 2006, Brenda Shackley, Department of Agriculture Performance of dwarf potential milling oat varieties in Western Australian environments, Raj Malik and Kellie Winfield, Department of Agriculture Field pea lessons for 2006, Rodger Beermir, Department of Agriculture Better returns from Durum wheat, Shahahan Miyan, Department of Agriculture Summer weeds can reduce grain yield and protein, Dr. Abul Hashem, Department of Agriculture, Dr Shahab Pathan, Department of Agriculture, Vikki Osten, Queensland Department of Primary Industries and Fisheries Management of Summer Weeds, Alex Douglas, Department of Agriculture Frost or Friction, Garren Knell, Steve Curtin, Wade Longmuir, Consult Ag Pty Ltd PROFITING FROM MARGINAL LAND SEMINAR Producing Bio-Diesel and rubber from marginal land?? Dr Henry Brockman, Department of Agriculture SGSL Producer network – on ground implementation of saltbush based pastures, Justin Hardy, Arjen Ryder, John Paul Collins and Jessica Johns, Department of Agriculture Enhancing the profitability of “Edenia” using saltbush and perenials, SGSL Producer case study, John Pepall, Jinka’s Hill LCDC Investment in saltland pastures, Allan Herbert, Department of Agricultur